In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
******************* * *
ALEXANDER THOMPSON, *
* No. 13-005V
Petitioner, * Special Master Christian J. Moran
*
v. * Filed: August 11, 2015
*
SECRETARY OF HEALTH * Stipulation; influenza (“flu”) vaccine;
AND HUMAN SERVICES, * Guillain-Barré Syndrome (“GBS”).
*
Respondent. *
****************** ** *
Michael Baseluos, Baseluos Law Firm, San Antonio, TX, for petitioner;
Julia McInerny, United States Dep’t of Justice, Washington, DC, for respondent.
UNPUBLISHED DECISION1
On August 7, 2015, respondent filed a joint stipulation concerning the
petition for compensation filed by Alexander Thompson on January 3, 2013. In his
petition, petitioner alleged that the influenza (“flu”) vaccine, which is contained in
the Vaccine Injury Table (the “Table”), 42 C.F.R. §100.3(a), and which he
received on October 22, 2010, caused him to suffer Guillain-Barré Syndrome
(“GBS”). Petitioner represents that there has been no prior award or settlement of
a civil action for damages on his behalf as a result of his condition.
Respondent denies that the vaccine caused petitioner to suffer from GBS or
any other injury.
1
The E-Government Act of 2002, Pub. L. No. 107-347, 116 Stat. 2899, 2913 (Dec. 17,
2002), requires that the Court post this decision on its website. Pursuant to Vaccine Rule 18(b),
the parties have 14 days to file a motion proposing redaction of medical information or other
information described in 42 U.S.C. § 300aa-12(d)(4). Any redactions ordered by the special
master will appear in the document posted on the website.
Nevertheless, the parties agree to the joint stipulation, attached hereto as
“Appendix A.” The undersigned finds said stipulation reasonable and adopts it as
the decision of the Court in awarding damages, on the terms set forth therein:
A. A lump sum of $380,000.00, in the form of a check payable to
petitioner, Alexander Thompson. This amount represents
compensation for all damages that would be available under U.S.C. §
300aa-15(a); and
B. An amount sufficient to purchase the annuity contract described in
paragraph 10 of the stipulation attached hereto as “Appendix A,”
paid to the life insurance company from which the annuity will be
purchased (the "Life Insurance Company").2
In the absence of a motion for review filed pursuant to RCFC, Appendix B,
the clerk is directed to enter judgment in case 13-005V according to this decision
and the attached stipulation.3
Any questions may be directed to my law clerk, Mary Holmes, at (202) 357-
6360.
IT IS SO ORDERED.
s/Christian J. Moran
Christian J. Moran
Special Master
2
The Life Insurance Company must have a minimum of $250,000,000 capital and
surplus, exclusive of any mandatory security valuation reserve. The Life Insurance Company
must have one of the following ratings from two of the following rating organizations:
a. A.M. Best Company: A++, A+, A+g, A+p, A+r, or A+s;
b. Moody's Investor Service Claims Paying Rating: Aa3, Aa2, Aa1, or Aaa;
c. Standard and Poor's Corporation Insurer Claims-Paying Ability Rating: AA-, AA,
AA+, or AAA;
d. Fitch Credit Rating Company, Insurance Company Claims Paying Ability Rating:
AA-, AA, AA+, or AAA.
3
Pursuant to Vaccine Rule 11(a), the parties can expedite entry of judgment by each
party filing a notice renouncing the right to seek review by a United States Court of Federal
Claims judge.
2
Case 1:13-vv-00005-UNJ Document 79 Filed 08/07/15 Page 1 of 6
Case 1:13-vv-00005-UNJ Document 79 Filed 08/07/15 Page 2 of 6
Case 1:13-vv-00005-UNJ Document 79 Filed 08/07/15 Page 3 of 6
Case 1:13-vv-00005-UNJ Document 79 Filed 08/07/15 Page 4 of 6
Case 1:13-vv-00005-UNJ Document 79 Filed 08/07/15 Page 5 of 6
Case 1:13-vv-00005-UNJ Document 79 Filed 08/07/15 Page 6 of 6